Quidel Corp
NASDAQ:QDEL
Quidel Corp
NASDAQ:QDEL
Price:
39.98 USD
-1.41%
Market Closed
Updated:
May 1, 2024
Quidel Corp
Operating Income
|
Quidel Corp
Operating Income Peer Comparison
Comparables:
HAE
COO
XRAY
ALGN
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Quidel Corp
NASDAQ:QDEL
|
Operating Income
$252.5m
|
CAGR 3-Years
-38%
|
CAGR 5-Years
18%
|
CAGR 10-Years
45%
|
|
|
Haemonetics Corp
NYSE:HAE
|
Operating Income
$199.3m
|
CAGR 3-Years
24%
|
CAGR 5-Years
13%
|
CAGR 10-Years
4%
|
|
|
Cooper Companies Inc
NYSE:COO
|
Operating Income
$536.7m
|
CAGR 3-Years
17%
|
CAGR 5-Years
5%
|
CAGR 10-Years
5%
|
|
|
DENTSPLY SIRONA Inc
NASDAQ:XRAY
|
Operating Income
$296m
|
CAGR 3-Years
2%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-4%
|
|
|
Align Technology Inc
NASDAQ:ALGN
|
Operating Income
$663.9m
|
CAGR 3-Years
7%
|
CAGR 5-Years
6%
|
CAGR 10-Years
14%
|
See Also
What is Quidel Corp's Operating Income?
Operating Income
252.5m
USD
252.5m
USD
Based on the financial report for Dec 31, 2023, Quidel Corp's Operating Income amounts to 252.5m USD.
What is Quidel Corp's Operating Income growth rate?
Operating Income CAGR 10Y
45%
45%
Over the last year, the Operating Income growth was -74%. The average annual Operating Income growth rates for Quidel Corp have been -38% over the past three years , 18% over the past five years , and 45% over the past ten years .
You don't have any saved screeners yet
